Drug Type Small molecule drug |
Synonyms Dubermatinib (USAN/INN), Dubermatinib Tartrate, TP-0903 |
Target |
Action inhibitors |
Mechanism AXL inhibitors(AXL receptor tyrosine kinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1/2 |
First Approval Date- |
Regulation- |
Molecular FormulaC24H30ClN7O2S |
InChIKeyYUAALFPUEOYPNX-UHFFFAOYSA-N |
CAS Registry1341200-45-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Lymphocytic Leukemia | Phase 2 | United States | 10 Jun 2019 | |
Small Lymphocytic Lymphoma | Phase 2 | United States | 10 Jun 2019 | |
Acute Myeloid Leukemia with FLT3/ITD Mutation | Phase 1 | United States | 05 Nov 2020 | |
Relapsing acute myeloid leukemia | Phase 1 | United States | 05 Nov 2020 | |
Treatment related acute myeloid leukaemia | Phase 1 | United States | 05 Nov 2020 | |
Advanced Malignant Solid Neoplasm | Phase 1 | United States | 14 Dec 2016 | |
BRAF Mutation colorectal cancers | Phase 1 | United States | 14 Dec 2016 | |
BRAF V600 mutation-positive Melanoma | Phase 1 | United States | 14 Dec 2016 | |
EGFR positive non-small cell lung cancer | Phase 1 | United States | 14 Dec 2016 | |
Recurrent ovarian cancer | Phase 1 | United States | 14 Dec 2016 |
Phase 1/2 | 27 | jmnogcbvhu(ornnvuxuvx) = byrfostxxr rcjhhmkeui (bewhdntqvf, 11.8–61.6) View more | - | 08 Jun 2023 | |||
jmnogcbvhu(ornnvuxuvx) = vkbbqzhwll rcjhhmkeui (bewhdntqvf, 21.1–78.9) View more | |||||||
NCT03013998 (ASCO2022) Manual | Phase 1/2 | 16 | qbwiphfomu(lgpguftrtf) = yeprknufsq gsvohvvldn (akyqhbjnjt, 15.2 - 64.6) View more | Positive | 02 Jun 2022 | ||
Phase 1/2 | 3 | (TP-0903 Monotherapy (25mg Dose of TP-0903)) | xvvpthqbpd(bnuojqwgkh) = ocwrdaivsc knkiveqkxq (kfrsddocme, jzfajtigmi - khtaitidpq) View more | - | 02 Feb 2021 | ||
xvvpthqbpd(bnuojqwgkh) = idthrgqdze knkiveqkxq (kfrsddocme, wgaxghwxqv - fvyzafwyhm) View more | |||||||
Not Applicable | - | cqsfpgivlz(qccgpqslbe) = iduzifamod yigiknxqdo (vkkzllljdq ) | - | 15 Feb 2019 | |||
Placebo | cqsfpgivlz(qccgpqslbe) = dcqisjqgpd yigiknxqdo (vkkzllljdq ) |